| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129 [M. G., C. P., J. B., V. I-T., Z. N., C. Y., G. M. S., E. V. S.]; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114 [M. G.]; Department of Medicine, University of Massachusetts Medical School, University of Massachusetts Memorial Healthcare, Worcester, Massachusetts 01655 [T. W.]; Department of Pathology, School of Medicine, University of California at Davis, Davis, California 95616 [R. D. C.]; The Pediatric Service, Massachusetts General Hospital, Boston, Massachusetts 02114 [Z. N., E. V. S.]; and Division of Hematology-Oncology, Childrens Hospital of Los Angeles, Los Angeles, California 90027 [G. M. S.]
A coordinated growth arrest during mammary involution completes the dramatic changes in mammary cell proliferation seen during pregnancy and lactation. Signals regulating this arrest are poorly understood, despite their potential relevance to oncogenesis. Here we report that the arrest involves a unique pulse of p16INK4A expression in vivo, which accompanies decreased cyclin D1 expression and a shift to an active repressor E2F4 complex. We used INK4A/ARF-/- mice as well as cyclin D1 and p16INK4A transgenic strains to examine the physiological significance of these patterns. p16INK4A directly regulated the in vivo transition from E2F3 to E2F4 as the major E2F DNA binding activity, and its contribution to growth arrest was independent of cyclin D1. Transgenic cyclin D1 expression prevented normal terminal differentiation by ablating the p16INK4A pulse, abolishing the shift from E2F3 to E2F4, derepressing E2F target genes, and expanding a stem cell population. The effects of cyclin D1 were reversed by restoring p16INK4A but were not seen in INK4A/ARF-/- mice. Our results indicate that cyclin D1 may contribute to tumorigenesis by altering cell differentiation and demonstrate a significant function for p16INK4A in development in vivo. These regulatory mechanisms used during mammary involution offer a potential explanation for the protective effect of pregnancy against breast cancer.
This article has been cited by other articles:
![]() |
S. M. Francis, J. Bergsied, C. E. Isaac, C. H. Coschi, A. L. Martens, C. V. Hojilla, S. Chakrabarti, G. E. DiMattia, R. Khoka, J. Y. J. Wang, et al. A Functional Connection between pRB and Transforming Growth Factor {beta} in Growth Inhibition and Mammary Gland Development Mol. Cell. Biol., August 15, 2009; 29(16): 4455 - 4466. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Andrechek, S. Mori, R. E. Rempel, J. T. Chang, and J. R. Nevins Patterns of cell signaling pathway activation that characterize mammary development Development, July 15, 2008; 135(14): 2403 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yang, S. Trent, V. Ionescu-Tiba, L. Lan, T. Shioda, D. Sgroi, and E. V. Schmidt Identification of Cyclin D1- and Estrogen-Regulated Genes Contributing to Breast Carcinogenesis and Progression Cancer Res., December 15, 2006; 66(24): 11649 - 11658. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Reynolds, M. Sigaroudinia, G. Zardo, M. B. Wilson, G. M. Benton, C. J. Miller, C. Hong, J. Fridlyand, J. F. Costello, and T. D. Tlsty Tumor Suppressor p16INK4A Regulates Polycomb-mediated DNA Hypermethylation in Human Mammary Epithelial Cells J. Biol. Chem., August 25, 2006; 281(34): 24790 - 24802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D'Amico, K. Wu, M. Fu, M. Rao, C. Albanese, R. G. Russell, H. Lian, D. Bregman, M. A. White, and R. G. Pestell The Inhibitor of Cyclin-Dependent Kinase 4a/Alternative Reading Frame (INK4a/ARF) Locus Encoded Proteins p16INK4a and p19ARF Repress Cyclin D1 Transcription through Distinct cis Elements Cancer Res., June 15, 2004; 64(12): 4122 - 4130. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yang, V. Ionescu-Tiba, K. Burns, M. Gadd, L. Zukerberg, D. N. Louis, D. Sgroi, and E. V. Schmidt The Role of the Cyclin D1-Dependent Kinases in ErbB2-Mediated Breast Cancer Am. J. Pathol., March 1, 2004; 164(3): 1031 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Borczuk, L. Gorenstein, K. L. Walter, A. A. Assaad, L. Wang, and C. A. Powell Non-Small-Cell Lung Cancer Molecular Signatures Recapitulate Lung Developmental Pathways Am. J. Pathol., November 1, 2003; 163(5): 1949 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Schmidt Genes Involved in Breast Cancer Progression: Analysis of Global Changes in Gene Expression or Retroviral Tagging? Am. J. Pathol., December 1, 2002; 161(6): 1973 - 1977. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |